Shook David

Insider profile

Performance

Overall performance
3.1

Performance over holding periods
3.1
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 6% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Shook David's trades of Lyell Immunopharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
212.53
Quantity 42,513 +15.9%
Value US$1,270,703
Transaction date
Sale
Price
401.68
Quantity 36,975 +9.8%
Value US$2,913,534
Transaction date
Sale
Price
5.60
Quantity 456 -0.4%
Value US$2,554
Transaction date
Sale
Price
8.74
Quantity 3,552 -3.0%
Value US$31,044
Transaction date
Sale
Price
1.83
Quantity 1,331 -2.2%
Value US$2,436
Transaction date
Planned sale
Price
4.85
Quantity 439 -0.7%
Value US$2,129
Transaction date
Sale
Price
5.49
Quantity 175 -0.3%
Value US$961
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-10 2026-09-10 S Sale
83,194 +0.9%
270.41
US$1,400,880
83,194 +0.9% 270.41 US$1,400,880
2026-06-11 2026-06-10 PlS Planned sale
42,513 +15.9%
212.53
US$1,270,703
42,513 +15.9% 212.53 US$1,270,703
2025-01-17 2025-01-15 S Sale
36,975 +9.8%
401.68
US$2,913,534
36,975 +9.8% 401.68 US$2,913,534
2024-06-20 2024-06-18 S Sale
456 -0.4%
5.60
US$2,554
456 -0.4% 5.60 US$2,554
2024-01-18 2024-01-16 S Sale
3,552 -3.0%
8.74
US$31,044
3,552 -3.0% 8.74 US$31,044
2023-08-23 2023-08-21 S Sale
1,331 -2.2%
1.83
US$2,436
1,331 -2.2% 1.83 US$2,436
2023-06-22 2023-06-20 PlS Planned sale
439 -0.7%
4.85
US$2,129
439 -0.7% 4.85 US$2,129
2023-01-18 2023-01-17 S Sale
175 -0.3%
5.49
US$961
175 -0.3% 5.49 US$961